LMP-specific T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LMP-specific T cells, covering 2020-02-07 to 2022-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder [Phase 2]